+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Oncology Clinical Trials Market Share, Size, Trends, Industry Analysis Report, By Phase; By Study Design; By Cancer Type; By Region; Segment Forecast, 2021 - 2028

  • PDF Icon

    Report

  • 117 Pages
  • May 2021
  • Region: Global
  • Polaris Market Research
  • ID: 5397028
The global oncology clinical trials market size is expected to reach USD 16.63 billion by 2028 according to this new study. The report “Oncology Clinical Trials Market Share, Size, Trends, Industry Analysis Report, By Phase (Phase I, Phase II, Phase III, Phase IV); By Study Design (Interventional, Observational, Expanded Access); By Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa); By Cancer Type; Segment Forecast, 2021-2028” gives a detailed insight into current market dynamics and provides analysis on future market growth.





Pancreatic cancer has a poor prognosis of just 1 to 3 years of survival. In a day, about 16 people were suffering from intestinal stromal tumors and around 60,000 new cases of renal carcinoma were observed in the - U.S alone. The factors listed above reflect a growing incidence of cancer and an increasing need for successful care for different forms of cancer. Study on cancer care is going ahead at a rapid rate.

A change from chemotherapy protocols to molecularly targeted immunotherapy agents has been observed. Cancer contin- U.S to present new problems and opportunities for pharmacological action. As a result, the pharmaceutical industry contin- U.S to produce oncology dr- U.S at an unprecedented pace.

In Asia Pacific, the market demand for oncology clinical trials is expected to witness the fastest growth over the forecast period, due to the growing availability of a wide patient pool to promote the recruitment of candidates. According to Asia Pacific’s largest expert biotech company CRO. The area has become the chosen destination for clinical studies due to the low density of the trial and a large number of active investigators.

Many biotechnological companies p- U.Suing CRO oncology services are increasingly turning to this field. For example, the EMA issued guidelines for accelerating the evaluation of qualifying medicines in 2015. In 2016, the Priority Medicines (PRIME) scheme was introduced to identify certain dr- U.S at an early stage of production that has the potential to meet unmet medical needs.

Market participants operating in the oncology clinical trials industry include PAREXEL International Corporation, PRA Health Sciences, Syneos Health, Medpace, Novotech, Pivotal, ICON Plc, Wuxi AppTec, Eli Lilly and Company, Novo Nordisk A/S, Pfizer, and Clinipace.

The publisher has segmented the oncology clinical trials market report on the basis of phase, study design, cancer type, and region:


Oncology Clinical Trials, Phase Outlook (Revenue-USD Million, 2016-2028)


  • Phase I
  • Phase II
  • Phase III
  • Phase IV

Oncology Clinical Trials, Study Design Outlook (Revenue-USD Million, 2016-2028)


  • Interventional
  • Observational
  • Expanded Access

Oncology Clinical Trials, Cancer Type Outlook (Revenue-USD Million, 2016-2028)


  • Lung cancer
  • Breast cancer
  • Thyroid cancer
  • Leukemia
  • Liver cancer
  • Skin cancer
  • Lymphoma
  • Pancreatic cancer
  • Prostate cancer
  • Colon & rectal cancer
  • Urinary system cancer
  • Other cancer

Oncology Clinical Trials, by Regional Outlook (Revenue-USD Million, 2016-2028)


  • North America
  • U.S
  • Canada
  • Europe
  • France
  • Germany
  • UK
  • Italy
  • Spain
  • Netherlands
  • Austria
  • Asia Pacific
  • China
  • India
  • Japan
  • Malaysia
  • South Korea
  • Indonesia
  • Central & South America
  • Mexico
  • Brazil
  • Argentina
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa
Frequently Asked Questions about the Oncology Clinical Trials Market

What is the estimated value of the Oncology Clinical Trials Market?

The Oncology Clinical Trials Market was estimated to be valued at $11.02 Billion in 2021.

What is the growth rate of the Oncology Clinical Trials Market?

The growth rate of the Oncology Clinical Trials Market is 5.6%, with an estimated value of $16.63 Billion by 2028.

What is the forecasted size of the Oncology Clinical Trials Market?

The Oncology Clinical Trials Market is estimated to be worth $16.63 Billion by 2028.

Who are the key companies in the Oncology Clinical Trials Market?

Key companies in the Oncology Clinical Trials Market include PAREXEL International Corporation, PRA Health Sciences, Syneos Health, Medpace, Novotech, Pivotal, ICON Plc, Wuxi AppTec and Novo Nordisk A/S.

Table of Contents

1. Introduction
1.1. Report Description
1.1.1. Objectives of the Study
1.1.2. Market Scope
1.1.3. Assumptions
1.2. Stakeholders
2. Executive Summary
2.1. Market Highlights
3. Research Methodology
3.1. Overview
3.1.1. Data Mining
3.2. Data Sources
3.2.1. Primary Sources
3.2.2. Secondary Sources
4. Oncology Clinical Trials Market Insights
4.1. Oncology Clinical Trials - Industry snapshot
4.2. Oncology Clinical Trials Market Dynamics
4.2.1. Drivers and Opportunities
4.2.1.1. Growing cancer cases
4.2.1.2. Innovations in personalized medicines
4.2.2. Restraints and Challenges
4.2.2.1. Lack of expertise
4.3. Porter’s Five Forces Analysis
4.3.1. Bargaining Power of Suppliers (Moderate)
4.3.2. Threats of New Entrants: (Low)
4.3.3. Bargaining Power of Buyers (Moderate)
4.3.4. Threat of Substitute (Moderate)
4.3.5. Rivalry among existing firms (High)
4.4. PESTLE Analysis
4.5. Oncology Clinical Trials Market Industry trends
4.6. COVID-19 Impact Analysis
5. Oncology Clinical Trials Market Assessment by Study Design
5.1. Key Findings
5.2. Introduction
5.2.1. Global Oncology Clinical Trials Market, By Study Design, 2016 - 2028 (USD Million)
5.3. Observational Trials
5.3.1. Global Oncology Clinical Trials Market, by Observational Trials, by Region, 2016- 2028 (USD Million)
5.4. Interventional Trials
5.4.1. Global Oncology Clinical Trials Market, by Interventional Trials, by Region, 2016- 2028 (USD Million)
5.5. Expanded Access Trials
5.5.1. Global Oncology Clinical Trials Market, by Expanded Access Trials, by Region, 2016- 2028 (USD Million)
6. Global Oncology Clinical Trials Market, by Cancer Type
6.1. Key Findings
6.2. Introduction
6.2.1. Global Oncology Clinical Trials Market, By Cancer Type, 2016 - 2028 (USD Million)
6.3. Lung cancer
6.3.1. Global Oncology Clinical Trials Market, by Lung cancer, By Region, 2016- 2028 (USD Million)
6.4. Breast cancer
6.4.1. Global Oncology Clinical Trials Market, by Breast cancer, by Region, 2016- 2028 (USD Million)
6.5. Thyroid cancer
6.5.1. Global Oncology Clinical Trials Market, by Thyroid cancer, by Region, 2016- 2028 (USD Million)
6.6. Leukemia
6.6.1. Global Oncology Clinical Trials Market, by Leukemia, by Region, 2016- 2028 (USD Million)
6.7. Liver cancer
6.7.1. Global Oncology Clinical Trials Market, by Liver cancer, by Region, 2016- 2028 (USD Million)
6.8. Skin cancer
6.8.1. Global Oncology Clinical Trials Market, by Skin cancer, by Region, 2016- 2028 (USD Million)
6.9. Lymphoma
6.9.1. Global Oncology Clinical Trials Market, by Lymphoma, by Region, 2016- 2028 (USD Million)
6.10. Pancreatic cancer
6.10.1. Global Oncology Clinical Trials Market, by Pancreatic cancer, by Region, 2016- 2028 (USD Million)
6.11. Prostate cancer
6.11.1. Global Oncology Clinical Trials Market, by Prostate cancer, by Region, 2016- 2028 (USD Million)
6.12. Colon & rectal cancer
6.12.1. Global Oncology Clinical Trials Market, by Colon & rectal cancer, by Region, 2016- 2028 (USD Million)
6.13. Urinary system cancer
6.13.1. Global Oncology Clinical Trials Market, by Urinary system cancer, by Region, 2016- 2028 (USD Million)
6.14. Other cancer
6.14.1. Global Oncology Clinical Trials Market, by Other cancer, by Region, 2016- 2028 (USD Million)
7. Global Oncology Clinical Trials Market, by Phases
7.1. Key Findings
7.2. Introduction
7.2.1. Global Oncology Clinical Trials Market, By Phases, 2016 - 2028 (USD Million)
7.3. Phase I
7.3.1. Global Oncology Clinical Trials Market, by Phase I, By Region, 2016- 2028 (USD Million)
7.4. Phase II
7.4.1. Global Oncology Clinical Trials Market, by Phase II, by Region, 2016- 2028 (USD Million)
7.5. Phase III
7.5.1. Global Oncology Clinical Trials Market, by Phase III, by Region, 2016- 2028 (USD Million)
7.6. Phase IV
7.6.1. Global Oncology Clinical Trials Market, by Phase IV, by Region, 2016- 2028 (USD Million)
8. Oncology Clinical Trials Market Assessment by Geography
8.1. Key findings
8.2. Introduction
8.2.1. Oncology Clinical Trials Market Assessment, By Geography, 2016- 2028 (USD Million)
8.3. Oncology Clinical Trials Market - North America
8.3.1. North America: Oncology Clinical Trials Market, By Study Design, 2016- 2028 (USD Million)
8.3.2. North America: Oncology Clinical Trials Market, By Cancer Type, 2016- 2028 (USD Million)
8.3.3. North America: Oncology Clinical Trials Market, By Phases, 2016 - 2028 (USD Million)
8.3.4. Oncology Clinical Trials Market - U.S.
8.3.4.1. U.S.: Oncology Clinical Trials Market, By Study Design, 2016- 2028 (USD Million)
8.3.4.2. U.S.: Oncology Clinical Trials Market, By Cancer Type, 2016- 2028 (USD Million)
8.3.4.3. U.S.: Oncology Clinical Trials Market, By Phases, 2016- 2028 (USD Million)
8.3.5. Oncology Clinical Trials Market - Canada
8.3.5.1. Canada: Oncology Clinical Trials Market, By Study Design, 2016- 2028 (USD Million)
8.3.5.2. Canada.: Oncology Clinical Trials Market, By Cancer Type, 2016- 2028 (USD Million)
8.3.5.3. Canada: Oncology Clinical Trials Market, By Phases, 2016- 2028 (USD Million)
8.4. Oncology Clinical Trials Market - Europe
8.4.1. Europe: Oncology Clinical Trials Market, By Study Design, 2016- 2028 (USD Million)
8.4.2. Europe.: Oncology Clinical Trials Market, By Cancer Type, 2016- 2028 (USD Million)
8.4.3. Europe: Oncology Clinical Trials Market, By Phases, 2016- 2028 (USD Million)
8.4.4. Oncology Clinical Trials Market - UK
8.4.4.1. UK: Oncology Clinical Trials Market, By Study Design, 2016- 2028 (USD Million)
8.4.4.2. UK.: Oncology Clinical Trials Market, By Cancer Type, 2016- 2028 (USD Million)
8.4.4.3. UK: Oncology Clinical Trials Market, By Phases, 2016- 2028 (USD Million)
8.4.5. Oncology Clinical Trials Market - France
8.4.5.1. France: Oncology Clinical Trials Market, By Study Design, 2016- 2028 (USD Million)
8.4.5.2. France.: Oncology Clinical Trials Market, By Cancer Type, 2016- 2028 (USD Million)
8.4.5.3. France: Oncology Clinical Trials Market, By Phases, 2016- 2028 (USD Million)
8.4.6. Oncology Clinical Trials Market - Germany
8.4.6.1. Germany: Oncology Clinical Trials Market, By Study Design, 2016- 2028 (USD Million)
8.4.6.2. Germany.: Oncology Clinical Trials Market, By Cancer Type, 2016- 2028 (USD Million)
8.4.6.3. Germany: Oncology Clinical Trials Market, By Phases, 2016- 2028 (USD Million)
8.4.7. Oncology Clinical Trials Market - Italy
8.4.7.1. Italy: Oncology Clinical Trials Market, By Study Design, 2016- 2028 (USD Million)
8.4.7.2. Italy.: Oncology Clinical Trials Market, By Cancer Type, 2016- 2028 (USD Million)
8.4.7.3. Italy: Oncology Clinical Trials Market, By Phases, 2016- 2028 (USD Million)
8.4.8. Oncology Clinical Trials Market - Spain
8.4.8.1. Spain: Oncology Clinical Trials Market, By Study Design, 2016- 2028 (USD Million)
8.4.8.2. Spain.: Oncology Clinical Trials Market, By Cancer Type, 2016- 2028 (USD Million)
8.4.8.3. Spain: Oncology Clinical Trials Market, By Phases, 2016- 2028 (USD Million)
8.4.9. Oncology Clinical Trials Market - Netherlands
8.4.9.1. Netherlands: Oncology Clinical Trials Market, By Study Design, 2016- 2028 (USD Million)
8.4.9.2. Netherlands.: Oncology Clinical Trials Market, By Cancer Type, 2016- 2028 (USD Million)
8.4.9.3. Netherlands: Oncology Clinical Trials Market, By Phases, 2016- 2028 (USD Million)
8.4.10. Oncology Clinical Trials Market - Austria
8.4.10.1. Austria: Oncology Clinical Trials Market, By Study Design, 2016- 2028 (USD Million)
8.4.10.2. Austria.: Oncology Clinical Trials Market, By Cancer Type, 2016- 2028 (USD Million)
8.4.10.3. Austria: Oncology Clinical Trials Market, By Phases, 2016- 2028 (USD Million)
8.5. Oncology Clinical Trials Market - Asia-Pacific
8.5.1. Asia Pacific: Oncology Clinical Trials Market, By Study Design, 2016- 2028 (USD Million)
8.5.2. Asia Pacific.: Oncology Clinical Trials Market, By Cancer Type, 2016- 2028 (USD Million)
8.5.3. Asia-pacific: Oncology Clinical Trials Market, By Phases, 2016- 2028 (USD Million)
8.5.4. Oncology Clinical Trials Market - China
8.5.4.1. China: Oncology Clinical Trials Market, By Study Design, 2016- 2028 (USD Million)
8.5.4.2. China.: Oncology Clinical Trials Market, By Cancer Type, 2016- 2028 (USD Million)
8.5.4.3. China: Oncology Clinical Trials Market, By Phases, 2016- 2028 (USD Million)
8.5.5. Oncology Clinical Trials Market - India
8.5.5.1. India: Oncology Clinical Trials Market, By Study Design, 2016- 2028 (USD Million)
8.5.5.2. India.: Oncology Clinical Trials Market, By Cancer Type, 2016- 2028 (USD Million)
8.5.5.3. India: Oncology Clinical Trials Market, By Phases, 2016- 2028 (USD Million)
8.5.6. Oncology Clinical Trials Market - Malaysia
8.5.6.1. Malaysia: Oncology Clinical Trials Market, By Study Design, 2016- 2028 (USD Million)
8.5.6.2. Malaysia.: Oncology Clinical Trials Market, By Cancer Type, 2016- 2028 (USD Million)
8.5.6.3. Malaysia: Oncology Clinical Trials Market, By Phases, 2016- 2028 (USD Million)
8.5.7. Oncology Clinical Trials Market - Japan
8.5.7.1. Japan: Oncology Clinical Trials Market, By Study Design, 2016- 2028 (USD Million)
8.5.7.2. Japan.: Oncology Clinical Trials Market, By Cancer Type, 2016- 2028 (USD Million)
8.5.7.3. Japan: Oncology Clinical Trials Market, By Phases, 2016- 2028 (USD Million)
8.5.8. Oncology Clinical Trials Market - Indonesia
8.5.8.1. Indonesia: Oncology Clinical Trials Market, By Study Design, 2016- 2028 (USD Million)
8.5.8.2. Indonesia.: Oncology Clinical Trials Market, By Cancer Type, 2016- 2028 (USD Million)
8.5.8.3. Indonesia: Oncology Clinical Trials Market, By Phases, 2016- 2028 (USD Million)
8.5.9. Oncology Clinical Trials Market - South Korea
8.5.9.1. South Korea: Oncology Clinical Trials Market, By Study Design, 2016- 2028 (USD Million)
8.5.9.2. South Korea.: Oncology Clinical Trials Market, By Cancer Type, 2016- 2028 (USD Million)
8.5.9.3. South Korea: Oncology Clinical Trials Market, By Phases, 2016- 2028 (USD Million)
8.6. Oncology Clinical Trials Market - Middle East & Africa
8.6.1. Middle East & Africa: Oncology Clinical Trials Market, By Study Design, 2016- 2028 (USD Million)
8.6.2. Middle East & Africa.: Oncology Clinical Trials Market, By Cancer Type, 2016- 2028 (USD Million)
8.6.3. Middle East & Africa: Oncology Clinical Trials Market, By Phases, 2016- 2028 (USD Million)
8.6.4. Oncology Clinical Trials Market - Saudi Arabia
8.6.4.1. Saudi Arabia: Oncology Clinical Trials Market, By Study Design, 2016- 2028 (USD Million)
8.6.4.2. Saudi Arabia.: Oncology Clinical Trials Market, By Cancer Type, 2016- 2028 (USD Million)
8.6.4.3. Saudi Arabia: Oncology Clinical Trials Market, By Phases, 2016- 2028 (USD Million)
8.6.5. Oncology Clinical Trials Market - UAE
8.6.5.1. UAE: Oncology Clinical Trials Market, By Study Design, 2016- 2028 (USD Million)
8.6.5.2. UAE.: Oncology Clinical Trials Market, By Cancer Type, 2016- 2028 (USD Million)
8.6.5.3. UAE: Oncology Clinical Trials Market, By Phases, 2016- 2028 (USD Million)
8.6.6. Oncology Clinical Trials Market - Israel
8.6.6.1. Israel: Oncology Clinical Trials Market, By Study Design, 2016- 2028 (USD Million)
8.6.6.2. Israel.: Oncology Clinical Trials Market, By Cancer Type, 2016- 2028 (USD Million)
8.6.6.3. Israel: Oncology Clinical Trials Market, By Phases, 2016- 2028 (USD Million)
8.6.7. Oncology Clinical Trials Market - South Africa
8.6.7.1. South Africa: Oncology Clinical Trials Market, By Study Design, 2016- 2028 (USD Million)
8.6.7.2. South Africa.: Oncology Clinical Trials Market, By Cancer Type, 2016- 2028 (USD Million)
8.6.7.3. South Africa: Oncology Clinical Trials Market, By Phases, 2016- 2028 (USD Million)
8.7. Oncology Clinical Trials Market - Latin America
8.7.1. Latin America: Oncology Clinical Trials Market, By Study Design, 2016- 2028 (USD Million)
8.7.2. Latin America.: Oncology Clinical Trials Market, By Cancer Type, 2016- 2028 (USD Million)
8.7.3. Latin America: Oncology Clinical Trials Market, By Phases, 2016- 2028 (USD Million)
8.7.4. Oncology Clinical Trials Market - Mexico
8.7.4.1. Mexico: Oncology Clinical Trials Market, By Study Design, 2016- 2028 (USD Million)
8.7.4.2. Mexico.: Oncology Clinical Trials Market, By Cancer Type, 2016- 2028 (USD Million)
8.7.4.3. Mexico: Oncology Clinical Trials Market, By Phases, 2016- 2028 (USD Million)
8.7.5. Oncology Clinical Trials Market - Brazil
8.7.5.1. Brazil: Oncology Clinical Trials Market, By Study Design, 2016- 2028 (USD Million)
8.7.5.2. Brazil.: Oncology Clinical Trials Market, By Cancer Type, 2016- 2028 (USD Million)
8.7.5.3. Brazil: Oncology Clinical Trials Market, By Phases, 2016- 2028 (USD Million)
8.7.6. Oncology Clinical Trials Market - Argentina
8.7.6.1. Argentina: Oncology Clinical Trials Market, By Study Design, 2016- 2028 (USD Million)
8.7.6.2. Argentina.: Oncology Clinical Trials Market, By Cancer Type, 2016- 2028 (USD Million)
8.7.6.3. Argentina: Oncology Clinical Trials Market, By Phases, 2016- 2028 (USD Million)
9. Competitive Landscape
9.1. Expansion and Acquisition Analysis
9.1.1. Expansion
9.1.2. Acquisitions
9.2. Partnerships/Collaborations/Agreements/Exhibitions
10. Company Profiles
10.1. Parexel International Corporation
10.1.1. Company Overview
10.1.2. Financial Performance
10.1.3. Product & Services Benchmarking
10.1.4. Recent Development
10.2. PRA Health Sciences
10.2.1. Company Overview
10.2.2. Financial Performance
10.2.3. Product & Services Benchmarking
10.2.4. Recent Development
10.3. Syneos Health
10.3.1. Company Overview
10.3.2. Financial Performance
10.3.3. Product & Services Benchmarking
10.3.4. Recent Development
10.4. Medpace
10.4.1. Company Overview
10.4.2. Financial Performance
10.4.3. Product & Services Benchmarking
10.4.4. Recent Development
10.5. Novotech
10.5.1. Company Overview
10.5.2. Financial Performance
10.5.3. Product & Services Benchmarking
10.5.4. Recent Development
10.6. Pivotal
10.6.1. Company Overview
10.6.2. Financial Performance
10.6.3. Product & Services Benchmarking
10.6.4. Recent Development
10.7. ICON Plc
10.7.1. Company Overview
10.7.2. Financial Performance
10.7.3. Product & Services Benchmarking
10.7.4. Recent Development
10.8. Wuxi AppTec
10.8.1. Company Overview
10.8.2. Financial Performance
10.8.3. Product & Services Benchmarking
10.8.4. Recent Development
10.9. Clinipace
10.9.1. Company Overview
10.9.2. Financial Performance
10.9.3. Product & Services Benchmarking
10.9.4. Recent Development
10.10. Medelis
10.10.1. Company Overview
10.10.2. Financial Performance
10.10.3. Product & Services Benchmarking
10.10.4. Recent Development
List of Tables
Table 1. Global Oncology Clinical Trials Market, By Study Design, 2016 - 2028 (USD Million)
Table 2. Global Oncology Clinical Trials Market, by Cancer Type, by Region, 2016 - 2028 (USD Million)
Table 3. Global Oncology Clinical Trials Market, by Phases , by Region, 2016 - 2028 (USD Million)
Table 4. Oncology Clinical Trials Market Assessment, By Geography, 2016 - 2028 (USD Million)
Table 5. North America: Oncology Clinical Trials Market, By Study Design, 2016 - 2028 (USD Million)
Table 6. North America: Oncology Clinical Trials Market, By Cancer Type, 2016 - 2028 (USD Million)
Table 7. North America: Oncology Clinical Trials Market, By Phases, 2016 - 2028 (USD Million)
Table 8. U.S.: Oncology Clinical Trials Market, By Study Design, 2016 - 2028 (USD Million)
Table 9. U.S.: Oncology Clinical Trials Market, By Cancer Type, 2016 - 2028 (USD Million)
Table 10. U.S.: Oncology Clinical Trials Market, By Phases, 2016 - 2028 (USD Million)
Table 11. Canada: Oncology Clinical Trials Market, By Study Design, 2016 - 2028 (USD Million)
Table 12. Canada: Oncology Clinical Trials Market, By Cancer Type, 2016 - 2028 (USD Million)
Table 13. Canada: Oncology Clinical Trials Market, By Phases, 2016 - 2028 (USD Million)
Table 14. Europe: Oncology Clinical Trials Market, By Study Design, 2016 - 2028 (USD Million)
Table 15. Europe: Oncology Clinical Trials Market, By Cancer Type, 2016 - 2028 (USD Million)
Oncology Clinical Trials Market Insights Europe: Oncology Clinical Trials Market, By Phases, 2016 - 2028 (USD Million)
Table 17. UK: Oncology Clinical Trials Market, By Study Design, 2016 - 2028 (USD Million)
Table 18. UK: Oncology Clinical Trials Market, By Cancer Type, 2016 - 2028 (USD Million)
Table 19. UK: Oncology Clinical Trials Market, By Phases, 2016 - 2028 (USD Million)
Table 20. France: Oncology Clinical Trials Market, By Study Design, 2016 - 2028 (USD Million)
Table 21. France: Oncology Clinical Trials Market, By Cancer Type, 2016 - 2028 (USD Million)
Table 22. France: Oncology Clinical Trials Market, By Phases, 2016 - 2028 (USD Million)
Table 23. Germany: Oncology Clinical Trials Market, By Study Design, 2016 - 2028 (USD Million)
Table 24. Germany: Oncology Clinical Trials Market, By Cancer Type, 2016 - 2028 (USD Million)
Table 25. Germany: Oncology Clinical Trials Market, By Phases, 2016 - 2028 (USD Million)
Table 26. Italy: Oncology Clinical Trials Market, By Study Design, 2016 - 2028 (USD Million)
Table 27. Italy: Oncology Clinical Trials Market, By Cancer Type, 2016 - 2028 (USD Million)
Table 28. Italy: Oncology Clinical Trials Market, By Phases, 2016 - 2028 (USD Million)
Table 29. Netherlands: Oncology Clinical Trials Market, By Study Design, 2016 - 2028 (USD Million)
Table 30. Netherlands: Oncology Clinical Trials Market, By Cancer Type, 2016 - 2028 (USD Million)
Table 31. Netherlands: Oncology Clinical Trials Market, By Phases, 2016 - 2028 (USD Million)
Table 32. Austria: Oncology Clinical Trials Market, By Study Design, 2016 - 2028 (USD Million)
Table 33. Austria: Oncology Clinical Trials Market, By Cancer Type, 2016 - 2028 (USD Million)
Table 34. Austria: Oncology Clinical Trials Market, By Phases, 2016 - 2028 (USD Million)
Table 35. Asia Pacific: Oncology Clinical Trials Market, By Study Design, 2016 - 2028 (USD Million)
Table 36. Asia Pacific: Oncology Clinical Trials Market, By Cancer Type, 2016 - 2028 (USD Million)
Table 37. Asia Pacific: Oncology Clinical Trials Market, By Phases, 2016 - 2028 (USD Million)
Table 38. China: Oncology Clinical Trials Market, By Study Design, 2016 - 2028 (USD Million)
Table 39. China: Oncology Clinical Trials Market, By Cancer Type, 2016 - 2028 (USD Million)
Table 40. China: Oncology Clinical Trials Market, By Phases, 2016 - 2028 (USD Million)
Table 41. India: Oncology Clinical Trials Market, By Study Design, 2016 - 2028 (USD Million)
Table 42. India: Oncology Clinical Trials Market, By Cancer Type, 2016 - 2028 (USD Million)
Table 43. India: Oncology Clinical Trials Market, By Phases, 2016 - 2028 (USD Million)
Table 44. Japan: Oncology Clinical Trials Market, By Study Design, 2016 - 2028 (USD Million)
Table 45. Japan: Oncology Clinical Trials Market, By Cancer Type, 2016 - 2028 (USD Million)
Table 46. Japan: Oncology Clinical Trials Market, By Phases, 2016 - 2028 (USD Million)
Table 47. Malaysia: Oncology Clinical Trials Market, By Study Design, 2016 - 2028 (USD Million)
Table 48. Malaysia: Oncology Clinical Trials Market, By Cancer Type, 2016 - 2028 (USD Million)
Table 49. Malaysia: Oncology Clinical Trials Market, By Phases, 2016 - 2028 (USD Million)
Table 50. Indonesia: Oncology Clinical Trials Market, By Study Design, 2016 - 2028 (USD Million)
Table 51. Indonesia: Oncology Clinical Trials Market, By Cancer Type, 2016 - 2028 (USD Million)
Table 52. Indonesia: Oncology Clinical Trials Market, By Phases, 2016 - 2028 (USD Million)
Table 53. South Korea: Oncology Clinical Trials Market, By Study Design, 2016 - 2028 (USD Million)
Table 54. South Korea: Oncology Clinical Trials Market, By Cancer Type, 2016 - 2028 (USD Million)
Table 55. South Korea: Oncology Clinical Trials Market, By Phases, 2016 - 2028 (USD Million)
Table 56. Middle East & Africa: Oncology Clinical Trials Market, By Study Design, 2016 - 2028 (USD Million)
Table 57. Middle East & Africa: Oncology Clinical Trials Market, By Cancer Type, 2016 - 2028 (USD Million)
Table 58. Middle East & Africa: Oncology Clinical Trials Market, By Phases, 2016 - 2028 (USD Million)
Table 59. Saudi Arabia: Oncology Clinical Trials Market, By Study Design, 2016 - 2028 (USD Million)
Table 60. Saudi Arabia: Oncology Clinical Trials Market, By Cancer Type, 2016 - 2028 (USD Million)
Table 61. Saudi Arabia: Oncology Clinical Trials Market, By Phases, 2016 - 2028 (USD Million)
Table 62. Israel: Oncology Clinical Trials Market, By Study Design, 2016 - 2028 (USD Million)
Table 63. Israel: Oncology Clinical Trials Market, By Cancer Type, 2016 - 2028 (USD Million)
Table 64. Israel: Oncology Clinical Trials Market, By Phases, 2016 - 2028 (USD Million)
Table 65. South Africa: Oncology Clinical Trials Market, By Study Design, 2016 - 2028 (USD Million)
Table 66. South Africa: Oncology Clinical Trials Market, By Cancer Type, 2016 - 2028 (USD Million)
Table 67. South Africa: Oncology Clinical Trials Market, By Phases, 2016 - 2028 (USD Million)
Table 68. Latin America: Oncology Clinical Trials Market, By Study Design, 2016 - 2028 (USD Million)
Table 69. Latin America: Oncology Clinical Trials Market, By Cancer Type, 2016 - 2028 (USD Million)
Table 70. Latin America: Oncology Clinical Trials Market, By Phases, 2016 - 2028 (USD Million)
Table 71. Brazil: Oncology Clinical Trials Market, By Study Design, 2016 - 2028 (USD Million)
Table 72. Brazil: Oncology Clinical Trials Market, By Cancer Type, 2016 - 2028 (USD Million)
Table 73. Brazil: Oncology Clinical Trials Market, By Phases, 2016 - 2028 (USD Million)
Table 74. Mexico: Oncology Clinical Trials Market, By Study Design, 2016 - 2028 (USD Million)
Table 75. Mexico: Oncology Clinical Trials Market, By Cancer Type, 2016 - 2028 (USD Million)
Table 76. Mexico: Oncology Clinical Trials Market, By Phases, 2016 - 2028 (USD Million)
Table 77. Argentina: Oncology Clinical Trials Market, By Study Design, 2016 - 2028 (USD Million)
Table 78. Argentina: Oncology Clinical Trials Market, By Cancer Type, 2016 - 2028 (USD Million)
Table 79. Argentina: Oncology Clinical Trials Market, By Phases, 2016 - 2028 (USD Million)
List of Figures
Figure 1. Market Highlights (2020, Revenue)
Figure 2. Integrated Ecosystem
Figure 3. Research Methodology: Top Down & Bottom Up Approach
Figure 4. Market by Geography
Figure 6. Porter’s Five Forces
Figure 7. Market by Study Design
Figure 8. Global Oncology Clinical Trials Market, By Study Design, 2020 & 2028 (USD Million)
Figure 9. Market by Cancer Type
Figure 8. Global Oncology Clinical Trials Market, By Cancer Type, 2020 & 2028 (USD Million)
Figure 9. Market by Phases
Figure 10. Global Oncology Clinical Trials Market, By Phases, 2020 & 2028 (USD Million)
Figure 13. Oncology Clinical Trials Market Assessment, By Geography, 2016- 2028 (USD Million)
Figure 14. Strategic Analysis - Oncology Clinical Trials Market

Companies Mentioned

  • PAREXEL International Corporation
  • PRA Health Sciences
  • Syneos Health
  • Medpace
  • Novotech
  • Pivotal
  • ICON Plc
  • Wuxi AppTec
  • Eli Lilly and Company
  • Novo Nordisk A/S
  • Pfizer
  • Clinipace.